Circulation, Vol 81, 593-601, Copyright © 1990 by American Heart Association
T Yamakado, H Okano, S Higashiyama, M Hamada, T Nakano and H Takezawa
We investigated the effects of nifedipine on left ventricular diastolic
function in 17 asymptomatic or minimally symptomatic patients with
hypertrophic cardiomyopathy by simultaneously measuring left ventricular
pressure and volume with a catheter-tipped manometer and biplane
cineangiography. Studies were performed before and 20 minutes after
sublingual administration of nifedipine (20 mg). Heart rates were held
constant (79 +/- 12 beats/min, mean +/- SD) by right atrial pacing. Left
ventricular volumes and instantaneous rates of left ventricular volume were
derived from frame-by-frame (20-msec) analyses of left ventricular biplane
angiograms. Left ventricular peak systolic pressure (from 122 +/- 21 to 108
+/- 13 mm Hg, p less than 0.01 vs. control) and mean aortic pressure (from
96 +/- 15 to 87 +/- 11 mm Hg, p less than 0.01) decreased significantly
with nifedipine. With afterload reduction, left ventricular ejection
fraction (from 0.69 +/- 0.12 to 0.74 +/- 0.08, p less than 0.01) and
cardiac output (from 6.4 +/- 2.0 to 7.2 +/- 2.2 l/mm, p less than 0.05)
increased significantly. However, there was a slight but significant
increase in left ventricular end-diastolic pressure (from 15 +/- 8 to 18
+/- 8 mm Hg, p less than 0.05). Nifedipine did not improve left ventricular
relaxation as assessed by the time constants of isovolumic pressure decay
(t1/2, from 39.8 +/- 6.6 to 39.4 +/- 7.7 msec, NS; t1/e, from 53.8 +/- 9.0
to 54.4 +/- 10.7 msec, NS).(ABSTRACT TRUNCATED AT 250 WORDS)
ARTICLES
Effects of nifedipine on left ventricular diastolic function in patients with asymptomatic or minimally symptomatic hypertrophic cardiomyopathy
First Department of Internal Medicine, Mie University, Tsu, Japan.
This article has been cited by other articles:
![]() |
M. A. Fifer and G. J. Vlahakes Management of Symptoms in Hypertrophic Cardiomyopathy Circulation, January 22, 2008; 117(3): 429 - 439. [Full Text] [PDF] |
||||
![]() |
O. I I Soliman, P. Knaapen, M. L Geleijnse, P. A Dijkmans, A. M Anwar, A. Nemes, M. Michels, W. B Vletter, A. A Lammertsma, and F. J ten Cate Assessment of intravascular and extravascular mechanisms of myocardial perfusion abnormalities in obstructive hypertrophic cardiomyopathy by myocardial contrast echocardiography Heart, October 1, 2007; 93(10): 1204 - 1212. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Kawada, H. Sakuma, T. Yamakado, K. Takeda, N. Isaka, T. Nakano, and C. B. Higgins Hypertrophic Cardiomyopathy: MR Measurement of Coronary Blood Flow and Vasodilator Flow Reserve in Patients and Healthy Subjects Radiology, April 1, 1999; 211(1): 129 - 135. [Abstract] [Full Text] |
||||
![]() |
T. Yamakado, E. Takagi, S. Okubo, K. Imanaka-Yoshida, T. Tarumi, M. Nakamura, and T. Nakano Effects of Aging on Left Ventricular Relaxation in Humans: Analysis of Left Ventricular Isovolumic Pressure Decay Circulation, February 18, 1997; 95(4): 917 - 923. [Abstract] [Full Text] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1990 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |